Article

The work force in 2013: Resources for urologists

Conference|AUA

Resources to help you understand the current state of the urology work force, including trends specific to your county, and future projections. Watch for updates to this page as they become available!

The following resources are designed to help you understand the current state of the urology work force, including trends specific to your county, and future projections.

Watch for updates to this page as they become available!

 

 

Find recent county-by-county changes in the distribution of U.S. urologists: 

 

View Dr. Christopher Gonzalez’ interview on the labor shortage and graduate medical education funding, conducted by Dr. Stephen Nakada:
 

 

Watch practicing urologists give their views on the shortage and what should be done about it (CLICK HERE to read their responses and those of other practicing MDs):
 

 

 

 

Related Videos
Related Content
Dr. Syan recaps AUA 2024 sessions on urodynamics, PTNS devices
May 24th 2024

Dr. Syan recaps AUA 2024 sessions on urodynamics, PTNS devices

Urology Times staff
Raveen Syan, MD, highlights 2 sessions that she took part in during the 2024 AUA Annual Meeting in San Antonio, Texas on urodynamics in the context of the VALUE trial and the new wave of percutaneous tibial nerve stimulation devices.
Speaking of Urology: 2023 AUA Highlights
May 12th 2023

Speaking of Urology: 2023 AUA Highlights

Urology Times staff
Adam B. Weiner, MD, and Ruchika Talwar, MD, discuss some of the notable urologic oncology abstracts that were presented at the 2023 AUA meeting.
Blue light cystoscopy decreases risk of recurrence, progression in NMIBC
May 9th 2024

Blue light cystoscopy decreases risk of recurrence, progression in NMIBC

Hannah Clarke
“The results of the BRAVO study performed within the VA health care system showed significant decreases in the risk of recurrence and progression, as well as the potential for improved overall survival in patients who received a BLC compared to patients who received WLC only,” says Stephen B. Williams, MD, MBA, MS, FACS, FACHE.
PUL yields superior early patient experience to WVTT for BPH
May 9th 2024

PUL yields superior early patient experience to WVTT for BPH

Hannah Clarke
Patients who received PUL experienced a greater reduction in inference regarding outdoor entertainment and community activities at 1 month vs WVTT.
Vibegron improves overactive bladder symptoms in pharmacologically treated BPH
May 7th 2024

Vibegron improves overactive bladder symptoms in pharmacologically treated BPH

Jason M. Broderick
There was a statistically significant reduction in average daily micturition episodes and average daily urgency episodes with vibegron vs placebo.
Real-world data show high darolutamide use for mHSPC in community urology setting
May 7th 2024

Real-world data show high darolutamide use for mHSPC in community urology setting

Kyle Doherty
Real-world data showed routine use of darolutamide regimens in community urology practice for patients with metastatic hormone-sensitive prostate cancer.
© 2024 MJH Life Sciences

All rights reserved.